{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:32:58Z","timestamp":1759332778172,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1038\/s41569-023-00954-3","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T19:01:55Z","timestamp":1699038115000},"page":"3-4","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term outcomes and device failure after TAVI"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-5437","authenticated-orcid":false,"given":"Marco","family":"Barbanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"954_CR1","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto, C. M. et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143, e72\u2013e227 (2021).","journal-title":"Circulation"},{"key":"954_CR2","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.jacc.2022.08.787","volume":"80","author":"T Sharma","year":"2022","unstructured":"Sharma, T., Krishnan, A. M., Lahoud, R., Polomsky, M. & Dauerman, H. L. National trends in TAVR and SAVR for patients with severe isolated aortic stenosis. J. Am. Coll. Cardiol. 80, 2054\u20132056 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"954_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/CIRCULATIONAHA.118.035150","volume":"138","author":"E Salaun","year":"2018","unstructured":"Salaun, E. et al. Rate, timing, correlates, and outcomes of hemodynamic valve deterioration after bioprosthetic surgical aortic valve replacement. Circulation 138, 971\u2013985 (2018).","journal-title":"Circulation"},{"key":"954_CR4","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1093\/eurheartj\/ehx303","volume":"38","author":"D Capodanno","year":"2017","unstructured":"Capodanno, D. et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 38, 3382\u20133390 (2017).","journal-title":"Eur. Heart J."},{"key":"954_CR5","doi-asserted-by":"publisher","first-page":"1242608","DOI":"10.3389\/fcvm.2023.1242608","volume":"10","author":"TT Lerman","year":"2023","unstructured":"Lerman, T. T. et al. Comparison of middle-term valve durability between transcatheter aortic valve implantation and surgical aortic valve replacement: an updated systematic review and meta-analysis of RCTs. Front. Cardiovasc. Med. 10, 1242608 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"954_CR6","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s10439-013-0785-7","volume":"41","author":"S Arjunon","year":"2013","unstructured":"Arjunon, S., Rathan, S., Jo, H. & Yoganathan, A. P. Aortic valve: mechanical environment and mechanobiology. Ann. Biomed. Eng. 41, 1331\u20131346 (2013).","journal-title":"Ann. Biomed. Eng."},{"key":"954_CR7","doi-asserted-by":"publisher","first-page":"Y33","DOI":"10.4244\/EIJV12SYA8","volume":"12","author":"M Barbanti","year":"2016","unstructured":"Barbanti, M. & Tamburino, C. Late degeneration of transcatheter aortic valves: pathogenesis and management. EuroIntervention 12, Y33\u2013Y36 (2016).","journal-title":"EuroIntervention"},{"key":"954_CR8","unstructured":"Jorgensen, J. et al. The Nordic Aortic Valve Intervention (NOTION) trial, 10 years follow-up. European Society of Cardiology Congress, https:\/\/esc365.escardio.org\/presentation\/272247?resource=slide (2023)."},{"key":"954_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jcin.2023.01.376","volume":"16","author":"GHL Tang","year":"2023","unstructured":"Tang, G. H. L. et al. Explant vs redo-TAVR after transcatheter valve failure: mid-term outcomes from the EXPLANTORREDO-TAVR international registry. JACC Cardiovasc. Interv. 16, 927\u2013941 (2023).","journal-title":"JACC Cardiovasc. Interv."},{"key":"954_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01636-7","author":"RR Makkar","year":"2023","unstructured":"Makkar, R. R. et al. Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(23)01636-7 (2023).","journal-title":"Lancet"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00954-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00954-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00954-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T14:11:56Z","timestamp":1702476716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00954-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1038\/s41569-023-00954-3","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"type":"print","value":"1759-5002"},{"type":"electronic","value":"1759-5010"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"3 November 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.B. is a consultant for Boston Scientific, Edwards Lifesciences and Medtronic. J.G.W. is a consultant for Edwards Lifesciences and has received research funding from Boston Scientific, Edwards Lifesciences and Medtronic.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}